TARSUS PHARMACEUTICALS INC (TARS) Institutional Ownership and Insiders Activity

TARSUS PHARMACEUTICALS INC (TARS) is widely held by institutional investors, with 250 firms reporting positions valued at approximately $2.95B based on SEC Form 13F filings for the quarter ended June 30, 2026.

Blackrock, Inc. is the largest disclosed holder, reporting approximately $242.71M in TARS holdings in its latest filing.

Recent insider activity includes 16 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.